The Peruvian Journal of Gynecology and Obstetrics http://51.222.106.123/index.php/RPGO <p>The Peruvian Journal of Gynecology and Obstetrics (Revista Peruana de Ginecologia y Obstetricia) is the official publication of the Peruvian Society of Obstetrics and Gynecology. Its purpose is to disseminate knowledge about gynecology, obstetrics, human reproduction and other topics related to women among its members and professionals of the specialty and related specialties and health professionals in general. The Peruvian Journal in Gynecology and Obstetrics is published quarterly in four issues that comprise, our journal is peer-reviewed and indexed in: LIPECS, LATINDEX, IMBIOMED, REDALYC, DOAJ, HINARI, REDIB, SciELO, DIALNET, ESCI Web of Science, MIAR.</p> es-ES <span>Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente la investigación al publico, lo cual fomenta un mayor intercambio de conocimiento global.</span> editorgeneral@spog.org.pe (Dr. José Pacheco Romero) pepe3190@hotmail.com (Dr. José Ramos Castillo) Mon, 07 Apr 2025 02:04:38 +0000 OJS 3.3.0.7 http://blogs.law.harvard.edu/tech/rss 60 Seventy years of the Peruvian Journal of Gynecology and Obstetrics http://51.222.106.123/index.php/RPGO/article/view/2741 <p>In September 1955, the first issue of the Revista Peruana de Ginecología <span style="font-size: 0.875rem; -webkit-text-size-adjust: 100%;">y Obstetricia (RPGO) was published, official publication of the Sociedad </span><span style="font-size: 0.875rem; -webkit-text-size-adjust: 100%;">Peruana de Obstetricia y Ginecología (SPOG) under the Presidency of </span><span style="font-size: 0.875rem; -webkit-text-size-adjust: 100%;">Dr. Eduardo Aguila Pardo, being Director de la RPGO, as he was named </span><span style="font-size: 0.875rem; -webkit-text-size-adjust: 100%;">the Editor, Dr. Lucas Molina Navia and co-Director Dr. Victor M. Bazúl.</span></p> Alfredo Guzmán Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2741 Mon, 07 Apr 2025 00:00:00 +0000 Wernicke's encephalopathy secondary to hyperemesis gravidarum http://51.222.106.123/index.php/RPGO/article/view/2734 <p>We report the case of a 32-year-old multigestational woman with 18 weeks of<br />gestation hospitalized for hyperemesis gravidarum. She was admitted with signs<br />of dehydration, weight loss (8.8%) and suffered fetal loss. There was evidence of<br />impaired consciousness, horizontal and vertical nystagmus and ataxia. A brain<br />tomography without contrast showed no alterations. Wernicke's encephalopathy<br />was diagnosed and thiamine was replaced, with a slow and favorable evolution.</p> Jorge Arturo Collantes Cubas, Luis Alberto Pinillos Vilca, Karla Esperanza Castañeda Bazán, Kelinda Nila Rosa Pajares Villar, Katia Jhesbith Núñez Ruiz, Paola Katherine Narro Bazán Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2734 Mon, 07 Apr 2025 00:00:00 +0000 Prenatal diagnosis and postnatal management of fetal ovarian cyst http://51.222.106.123/index.php/RPGO/article/view/2735 <p>Los quistes de ovario en el feto son las tumoraciones que se detectan con mayor</p> <p>frecuencia en la etapa prenatal. Se diagnostican ecográficamente durante el tercer</p> <p>trimestre a nivel abdominal como una imagen anecogénica, unilocular, en la que</p> <p>puede estar presente el signo del ‘quiste hijo’. Se debe realizar el diagnóstico</p> <p>diferencial con otras lesiones quísticas intraabdominales. El tamaño del quiste, las</p> <p>características ecográficas y la presencia de síntomas o complicaciones serán los</p> <p>determinantes para el manejo perinatal, en la que se incluye el manejo conservador,</p> <p>la aspiración prenatal del quiste y la cirugía posnatal. Se comunica el caso de una</p> <p>gestante de 30 semanas con feto femenino que presentó un quiste abdominal</p> <p>dependiente de anexo que en el transcurso de sus controles ecográficos mostró</p> <p>un incremento en el tamaño y un cambio en el patrón ecográfico. Durante la etapa</p> <p>posnatal requirió de un manejo quirúrgico vía laparoscópica, con evolución favorable</p> <p>y seguimiento por consultorio externo sin complicaciones.</p> Jorge Luis Minchola Vega, Rider Guerrero Campos Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2735 Mon, 07 Apr 2025 00:00:00 +0000 Impact of obesity on women's health http://51.222.106.123/index.php/RPGO/article/view/2742 <p>Throughout history, obesity has been perceived in different ways, sometimes as<br />a symbol of health and prosperity, and sometimes as a disease. Nowadays, there<br />is consensus in considering it as a chronic disease characterized by excessive fat<br />accumulation and linked to cardiovascular diseases, diabetes and pregnancy<br />complications. It is most commonly diagnosed by means of the Body Mass Index<br />(BMI). BMI often does not accurately reflect the problem. For this reason, other<br />methods such as Bioelectrical Impedance Analysis (BIA) and Dual Energy X-ray<br />Absorptiometry (DXA) have been proposed. Anthropometric parameters such as<br />skinfold thickness and mid-arm circumference are also used. Obesity is a global public<br />health problem whose prevalence has been increasing in recent decades. In Peru, it<br />is estimated that two-thirds of women of reproductive age have a BMI ≥ 25. There<br />are genetic and environmental factors involved in the development of obesity. The<br />metabolic changes associated with obesity are reviewed, including hyperinsulinemia<br />and hyperandrogenism, increased leptin and other pro-inflammatory adipokines,<br />and decreased adiponectin. Obese women have a higher risk of developing insulin<br />resistance, type 2 diabetes mellitus, dyslipidemia, coronary heart disease and high<br />blood pressure. The prevalence of menstrual irregularities due to anovulation<br />and infertility increases, with a lower rate of live births in in vitro fertilization (IVF)<br />treatments, and an increase in the abortion rate. Postmenopausal women tend to<br />gain weight, due to hormonal changes and less physical activity, with a preferential<br />increase in visceral fat. In obese women, the risk of breast, endometrial and<br />ovarian cancer increases. Obese pregnant women have a higher risk of developing<br />gestational diabetes and preeclampsia, fetal macrosomia and congenital anomalies.<br />It is important to prevent obesity with early education programs regarding the<br />short- and long-term medical consequences of obesity, and the promotion of<br />healthy lifestyles. Treatment includes diet and exercise, and medical and surgical<br />management options.</p> Adolfo Rechkemmer, Santiago Cabrera Ramos Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2742 Mon, 07 Apr 2025 00:00:00 +0000 Obesity in pregnancy http://51.222.106.123/index.php/RPGO/article/view/2743 <p>The pathophysiology of obesity includes adipose tissue dysfunction, alterations in<br />adipokine secretion and chronic inflammation, which contribute to insulin resistance.<br />During pregnancy, this increases the risk of complications such as gestational<br />diabetes, preeclampsia, miscarriage, premature delivery and fetal death. In addition,<br />obesity is linked to an increased risk of cesarean section, anesthetic complications,<br />postoperative infections and venous thromboembolism. Management of obesity<br />in this setting focuses on behavioral and lifestyle interventions, limiting excessive<br />weight gain. The use of weight-reducing medications is contraindicated, while<br />bariatric surgery may be an option if performed in the preconceptional state.</p> Santiago Cabrera Ramos Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2743 Mon, 07 Apr 2025 00:00:00 +0000 Obesity and menopausal transition http://51.222.106.123/index.php/RPGO/article/view/2744 <p>Obesity is a chronic multifactorial disease influenced by biological, psychological, and<br />environmental determinants, with a higher prevalence in women. It is associated with<br />chronic inflammation, metabolic disturbances, and an increased risk of cardiovascular<br />diseases and cancer. In postmenopause, the hormonal changes characteristic of this<br />stage affect body composition and energy metabolism, promoting an increase in<br />visceral adiposity. Oestrogen decline favours fat redistribution towards the abdomen,<br />which increases insulin resistance and the prevalence of metabolic syndrome. This<br />process is accompanied by a reduction in resting energy expenditure and lean mass,<br />without significant variations in body mass index (BMI). It is important to emphasise<br />that body fat distribution is a more accurate predictor of cardiometabolic risk<br />than BMI. Additionally, obesity influences the menopausal transition, exacerbating<br />symptoms such as hot flushes, sleep disorders, and sexual dysfunction, as well as<br />increasing the risk of urinary incontinence, sleep apnoea, and cognitive impairment,<br />partly due to systemic inflammation induced by adipokines. Moreover, obesity<br />also increases the risk of cancer, particularly endometrial and breast cancer, as it<br />is associated with greater exposure to endogenous oestrogens. Given the increase<br />in life expectancy, a growing number of women will spend a significant portion<br />of their lives in postmenopause, a stage in which obesity is highly prevalent. This<br />underscores the need to address obesity as a priority public health issue due to its<br />impact on quality of life and the risk of chronic diseases.</p> Eliana Ojeda-Lazo, Juan Enrique Blümel Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2744 Mon, 07 Apr 2025 00:00:00 +0000 Obesity and its impact on reproductive medicine http://51.222.106.123/index.php/RPGO/article/view/2745 <p>Obesity has a negative impact on reproductive health, with a higher incidence of<br />anovulation, menstrual disorders and infertility. The increase in adipose tissue<br />is associated with insulin resistance and hyperinsulinemia, reduction in sex<br />hormone binding globulin levels, and hyperandrogenemia. There is an increase<br />in pro-inflammatory adipokines and a decrease in adiponectins. Female obesity is<br />associated with ovulatory dysfunction, lower ovarian response to ovulation inducers,<br />decreased oocyte quantity and quality, and alteration in endometrial receptivity.<br />Likewise, a decrease in the live birth rate has been reported in in vitro fertilization<br />treatments, and an increase in the frequency of abortions. Male obesity increases the<br />incidence of erectile dysfunction and alterations in sperm quality. Diet, exercise, and<br />medical therapy have been shown to be effective. Bariatric surgery is an alternative<br />in cases of body mass index greater than 40, and achieves a rapid and effective<br />weight reduction, with improvement in metabolic parameters; it is recommended<br />to postpone pregnancy in women for at least one year after surgery. Bariatric<br />surgery significantly reduces the risk of fetal macrosomia, pregnancy-associated<br />hypertension, and gestational diabetes. However, it increases the risk of maternal<br />anemia and small-for-gestational-age newborns.</p> Adolfo Rechkemmer Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2745 Mon, 07 Apr 2025 00:00:00 +0000 Obesity and gynecological cancer http://51.222.106.123/index.php/RPGO/article/view/2746 <p>Obesity is a growing public health problem and its association with some chronic<br />diseases, including some types of cancer, mainly breast cancer and endometrial<br />cancer, is increasingly clear. In this review we analyze some mechanisms of this<br />relationship, such as: aromatization in fatty tissue, insulin resistance, chronic<br />inflammation and immune dysfunction.</p> Oscar Galdos Kajatt, Roxana Cárdenas de Galdos, Gino Venegas Rodriguez Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2746 Mon, 07 Apr 2025 00:00:00 +0000 Clinical, radiological and histopathological correlation in breast lesions: 10 years of experience http://51.222.106.123/index.php/RPGO/article/view/2729 <p>Introduction: Breast cancer remains a global public health problem. It is estimated<br />that its incidence will increase in the coming years. It is important to evaluate<br />screening studies in breast clinics through indicators in order to obtain an adequate<br />clinical, imaging and histopathological correlation. Objectives: To evaluate the<br />correlation between clinical, radiological and histopathological studies in women<br />who underwent breast cancer screening tests over a 10-year period. Methods: A<br />cross-sectional, descriptive, retrospective cohort study was conducted using the<br />records of a referral center from June 2013 to June 2023, of women who underwent<br />breast cancer screening. In those who underwent biopsy, the samples were analyzed<br />at our institution. Results: The records of 6 754 women who met the inclusion criteria<br />were analyzed, where the average age of the study population was 50.7 years. It was<br />recorded that 73.2% of the studies were categorized BI-RADS 2 and the majority of<br />the participants were asymptomatic. Of those 551 women who received a BI-RADS<br />&gt;4 mammogram, 226 (41%) had a malignant result. Conclusions: Mammography<br />has been shown to be the only imaging tool that has managed to have an impact<br />on mortality. There are modalities, such as tomosynthesis, that have increased<br />the performance of this test. It is valid to use new technologies to maintain quality<br />standards in the studies.</p> Leopoldo Santiago Sanabria, Julieta Garza Arrieta, Daniela Contreras Estrada, Adalberto Rochin Benoit, Bernardo Sánchez Alquicira, Montserrat Malfavón Farias, Luz del Carmen Sanabria Villegas Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2729 Mon, 07 Apr 2025 00:00:00 +0000 Characteristics of Extreme Maternal Morbidity at the Regional Hospital of Ayacucho, Peru, 2021-2023 http://51.222.106.123/index.php/RPGO/article/view/2730 <p>Extreme maternal morbidity (EMM), according to WHO, is a condition in which a<br />woman nearly almost loses her life due to complications during pregnancy, childbirth,<br />or the postpartum period. This rate is higher in low- and middle-income countries.<br />Although maternal mortality has declined in Peru, the EMM is not fully described,<br />underlining the importance of its analysis to improve maternal health services.<br />Objective: To describe EMM in the Regional Hospital of Ayacucho, Peru, between<br />June 2021 and June 2023, and to analyze key indicators to improve maternal care.<br />Materials and methods: An observational, retrospective, cross-sectional study was<br />conducted with 100 cases of EMM. Socio-demographic data, obstetric characteristics,<br />pathological history and interventions were assessed using epidemiological<br />surveillance forms and formulas to calculate the EMM, maternal mortality ratio and<br />other metrics. Results: The mean age of the patients was 28 years, mostly cohabiting<br />women with secondary education. The most frequent criteria for EMM were severe<br />hypoxia (50%) and cardiovascular compromise (39%). HELLP syndrome (30%) and<br />postpartum hemorrhage (22%) were the most common complications. The EMM was<br />19.4 per 1,000 live births and the maternal mortality ratio was 5.75 per 100 cases of<br />EMM. Conclusions: The EMM in Ayacucho (2021-2023) reveals severe complications<br />mainly in young women with low educational level. It is crucial to implement effective<br />prevention and management strategies to reduce its incidence and improve obstetric<br />outcomes.</p> Ramiro Rojas, Pablo Salinas-Alvarado, Jorge Pomacanchari-Llantoy, Gisela Tipe, Kenyo D. Sandoval, Víctor Palomino-Vargas Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2730 Mon, 07 Apr 2025 00:00:00 +0000 Comparison between clinical-ultrasound and pathological tumor size in breast cancer. Descriptive study http://51.222.106.123/index.php/RPGO/article/view/2731 <p>Introduction: Clinical evaluation of tumor size in the TNM classification is an integral<br />part of the diagnosis of breast carcinoma. The surgical decision depends largely on</p> <p>the clinical stage. Objective: To determine the concordance between the clinical-<br />ultrasound and pathological size of invasive breast carcinoma. Materials and</p> <p>methods: Observational, retrospective study. Surgical pathology and ultrasound<br />reports of patients with invasive breast carcinoma were reviewed. Data from 271<br />cases were included. Concordance was defined as a size difference equal to or<br />less than 5 mm. Demographic and clinical data were collected and analyzed using<br />descriptive statistics. Results: Concordance between clinical and pathological<br />tumor size was 30.8% (n: 73), and ultrasound was 52.9% (n: 18). The mean clinical<br />size was 33 mm (SD: 17.4), ultrasound was 11.3 mm (SD: 6.8) and pathological was<br />22.2 mm (SD: 14.4). The Student t test showed a significant difference in clinical<br />measurement (t= 7.5 mm, 95% CI 7.33 - 12.5; p: 0.000), Pearson correlation (r: 0.224;<br />p: 0.001) and ultrasound measurement (t: 3.83 mm, 95% CI 2.27 - 7.40; p: 0.001),<br />Pearson correlation (r: 0.342; p: 0.048). There were significant clinical-pathological<br />differences by clinical stages. Conclusions: In the sample studied, it was found that<br />the clinical and ultrasound measurement of tumor size had a low correlation with<br />the pathological tumor size, clinically there was a tendency to overestimate and<br />ultrasound to underestimate, affecting the clinical classification (TNM) for tumor size.</p> Oscar Alejandro Bonilla Sepúlveda Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2731 Mon, 07 Apr 2025 00:00:00 +0000 Ovarian reserve and pregnancy prognosis in in vitro fertilization http://51.222.106.123/index.php/RPGO/article/view/2733 <p>Introduction: The woman’s age and ovarian reserve are the most important factors<br />in fertility treatment. Ovarian reserve can be calculated through antral follicle count<br />(AFC) with vaginal ultrasound, providing valuable information on the pregnancy<br />prognosis in assisted reproduction. Objective: To define the significance of AFC in the<br />pregnancy prognosis in in vitro fertilization. Methods: Retrospective observational<br />study in which the clinical records of 508 infertile patients who underwent in vitro<br />fertilization at the Centro de Fertilidad y Ginecología del Sur from December 2005 to<br />April 2024 were reviewed. The clinical pregnancy rate in women with AFC ≥ 5 and in<br />those with AFC &lt; 5 is analyzed and compared with the differences found according<br />to age. Results: The clinical pregnancy rate in women with AFC ≥ 5 was 35.2%, while it<br />was 14.3% in women with AFC &lt; 5 (p = 0.0236), and was 41.9% in patients &lt; 35 years<br />and 27.2% in those ≥ 35 years (p = 0.0005). Differences in clinical pregnancy rate are<br />more transcendent when considering AFC rather than age (Odds Ratio: 3.3 versus<br />1.9, respectively). Conclusions: Patients with AFC &lt; 5 have three times lower clinical<br />pregnancy rate in IVF than those with greater ovarian reserve.</p> Luis Vargas-Tominaga, Yolanda Guerra, Andrea Medina, Andrea Vargas, Patricia Vargas, Nicolás Vargas, Daniella Miranda, Flor Huillca, Maritza Gómez Copyright (c) 2025 https://creativecommons.org/licenses/by/4.0 http://51.222.106.123/index.php/RPGO/article/view/2733 Mon, 07 Apr 2025 00:00:00 +0000